Adrian Woolfson

R&D

A new technology just announced this weekend in a paper in Nature could have a radical impact on how gene assembly is carried out.

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.